PEDIATRICS Vol. 94 No. 6 December 1994, pp. 892-894
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levine, D.
Right arrow Articles by Parry, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levine, D.
Right arrow Articles by Parry, M. F.

False Positive EBNA IgM and IgG Antibody Tests for Infectious Mononucleosis in Children

Dorothy Levine MD1, Rosemary Klenk MD1, Alan Morelli MD1, Nancy Hofreuter MD1, Richard C. Tilton PhD2, and Michael F. Parry MD3

1 New England Pediatrics and the Stamford Hospital
2 North American Laboratory Group, Inc
3 Columbia University College of Physicians and Surgeons

Objectives. To assess the reliability of the Monolert test, a new enzyme-linked immunosorbent assay for the diagnosis of acute infectious mononucleosis (IM).

Design. A retrospective laboratory and clinical analysis of 38 children diagnosed with acute IM.

Setting. A suburban pediatric practice in Connecticut.

Patients. Thirty-eight children (ages 18 months to 17 years) who were diagnosed with acute IM using the Monolert test during the period October 1992 to August 1993.

Results. Eighty-three percent of these children had no evidence of Epstein-Barr virus infection on subsequent investigation. The false positive results of the Monolert test could not be explained on the basis of elevated antibody titers to either cytomegalovirus or Borrelia burgdorferi.

Conclusion. Monolert is a poor screening test and is of little apparent value as a diagnostic test for acute Epstein-Barr virus infection in pediatric patients.

Submitted on January 6, 1994
Accepted on April 4, 1994




This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
A. Orti, M. C. Otero, P. Tallon, R. Merlos, D. Perez-Tamarit, A. Morant, J. Cordoba, and F. Asensi
Epstein-Barr Virus Mononucleosis: Neurologic Complications
Clinical Pediatrics, May 1, 2003; 42(4): 361 - 364.
[PDF]

Home page
 J. Clin. Microbiol.Home page
D. Tranchand-Bunel, H. Gras-Masse, B. Bourez, L. Dedecker, and C. Auriault
Evaluation of an Epstein-Barr Virus (EBV) Immunoglobulin M Enzyme-Linked Immunosorbent Assay Using a Synthetic Convergent Peptide Library, or Mixotope, for Diagnosis of Primary EBV Infection
J. Clin. Microbiol., July 1, 1999; 37(7): 2366 - 2368.
[Abstract] [Full Text]

Home page
 JAMAHome page
D. Levine, R. Grossberg, R. Tilton, P. Banks, and A. Rosenfeld
Are Current Regulations for Approval of In Vitro Diagnostic Devices Adequate?
JAMA, July 8, 1998; 280(2): 187 - 189.
[Full Text] [PDF]

Home page
 PediatricsHome page
D. Levine, R. Klenk, A. Morelli, N. Hofreuter, and H. Hoffmeister
Let the User Beware: Specificity and Sensitivity Limits for In Vitro Diagnostic Devices
Pediatrics, August 1, 1997; 100(2): 267 - 267.
[Full Text] [PDF]

Home page
 JWatch GeneralHome page
MONOLERT IS UNRELIABLE IN CHILDREN
Journal Watch (General), December 16, 1994; 1994(1216): 5 - 5.
[Full Text]